Soligenix, Inc.

Soligenix, Inc.

Soligenix, Inc.

Developing life-saving products and #vaccines for inflammatory diseases and #biodefense. $SNGX
Type
B2b
Raised
$17M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$1,500,000
Grant - 2017
National Cancer Institute (NCI)
$2,500,000
Post-IPO equity - 2017
Team Size
10+
Employees
$2,500,000 Post-IPO equity
prnewswire

Soligenix Receives $2.5M in Additional NIAID Funding to Advance Development of Heat Stable Ricin Vaccine